As of January 27, the global tally of SARS-CoV-2 infections has surpassed 100 million, with fatalities reaching 2 million. Remarkably, approximately 30 million confirmed cases remain untreated with ...
Video above: Johnson & Johnson vaccine developed with previously tested technologyThe practice of finding new uses for old medications — called repurposing or repositioning drugs — is not new.The most ...
In a group of health-related headlines, one says "Hope for new drug approach. As government-supported research in the US is being decimated by funding cuts, it was refreshing to attend iDR25 (the ...
As the summer of 2021 started to unfold, many Americans thought the pandemic was beginning to fizzle out. But that illusion is over and the country is once more besieged by the coronavirus. Intensive ...
We're all familiar with the dilemma: It takes an average of 9.5 to 15 years to develop a new drug at a cost as high as $2.6 billion, with only a fraction of the drugs making it to market. With AI and ...
London, July 1, 2024: The Drug Repurposing & Repositioning Inventions Boardroom provided a deep dive on this important topic with industry experts from NLO, 3D-PharmXchange, and the Repo4EU consortium ...
In a study published in the journal Nature Communications, researchers screened ReFRAME (short for repurposing, focused rescue, and accelerated Medchem), a drug-repurposing library, for drugs against ...
Finding a new medicine is never easy. But developing treatments for patients with rare diseases — conditions that afflict fewer than 200,000 people in the United States — is particularly challenging.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback